论文部分内容阅读
目的对莫西沙星联合阿奇霉素治疗支原体肺炎的临床治疗效果进行探讨和分析。方法选择75例于2012年9月至2013年10月在我院进行支原体肺炎治疗的患者,将其分为两组,对照组患者采用阿奇霉素治疗,治疗组患者采用莫西沙星联合阿奇霉素治疗,对两组患者的临床治疗效果进行比较和分析。结果对照组治疗总有效率为72%;治疗组治疗总有效率为96%,两组患者治疗总有效率差异具有统计学意义(P<0.05)。结论对支原体肺炎患者应用莫西沙星联合阿奇霉素治疗能够取得更为满意的临床治疗效果。
Objective To investigate and analyze the clinical effect of moxifloxacin combined with azithromycin in the treatment of mycoplasma pneumonia. Methods Seventy-five patients with mycoplasma pneumonia were treated in our hospital from September 2012 to October 2013. The patients in the control group were treated with azithromycin. The patients in the treatment group were treated with moxifloxacin combined with azithromycin. The clinical efficacy of the two groups were compared and analyzed. Results The total effective rate of the control group was 72%. The total effective rate of the treatment group was 96%. The total effective rate of the two groups was statistically significant (P <0.05). Conclusion The application of moxifloxacin combined with azithromycin in patients with mycoplasma pneumonia can achieve more satisfactory clinical treatment.